长期的恶性瘤风险:苏丹喀土穆教学医院的一项回顾性研究
Mohamed A Ali1, Mohamed ElMakki Ahmed2
1Surgery, Sudan Medical Specialization Board, Khartoum, SDN.
Cureus
|July 29, 2025
概括
在苏丹的长期中发现了大量的恶性瘤,卵泡癌是最常见的类型. 许多甲状腺癌病例是偶然发现的,强调了彻底的手术前评估.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 手术病理学手术病理学
背景情况:
- 喉在苏丹很普遍,呈现出不同的临床特征.
- 长期存在的带有很低但令人担忧的恶性瘤风险,随时间持续而增加.
- 建议在长期子时进行外科手术,以减轻恶性瘤的风险.
研究的目的:
- 评估长期的恶性瘤风险.
- 在接受甲状腺切除术的患者中识别恶性转变亚型.
- 在苏丹喀土穆教学医院评估甲状腺切除术结果.
主要方法:
- 卡尔图姆教学医院的回顾性描述性研究 (2017年3月至2018年9月).
- 包括160名患有长期的患者 (≥18岁),接受了甲状腺切除术.
- 分析了人口统计,临床数据和组织病理学方面的患者记录;使用SPSS (p<0.05) 进行统计分析.
主要成果:
- 在32.5%的患者 (54/160) 中检测到恶性瘤,其中卵泡癌最常见.
- 压力症状影响了94.4%的患者,11人患有喉神经复发性损伤,5人患有转移.
- 恶性瘤的临床怀疑和组织病理学确认之间的显著关联 (P=0.001).
结论:
- 在苏丹,长期存在的喉显示出显著的恶性瘤率,主要是卵泡癌.
- 甲状腺癌的偶然发现是常见的,这强调了需要仔细的手术前评估的必要性.
- 加强手术前评估和患者咨询对于流行性瘤地区至关重要.
相关概念视频
Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...


